1
|
Levy A, Roux C, Mercier O, Issard J, Botticella A, Barlesi F, Le Péchoux C. [Radiotherapy for oligometastatic non-small cell lung cancer patients]. Cancer Radiother 2021; 25:517-522. [PMID: 34175225 DOI: 10.1016/j.canrad.2021.06.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2021] [Accepted: 06/05/2021] [Indexed: 10/21/2022]
Abstract
The oligometastatic disease concept suggests that patients with a limited number of metastases have a favorable prognosis. Radical local treatment of oligometastatic patients has then increased given developments in imaging (mainly positron emission tomography and brain magnetic resonance imaging) and access to effective and better tolerated treatments. Stereotactic radiotherapy has the advantage of being noninvasive, allowing a good rate of local control and a limited number of side effects. A better definition of oligometastatic disease, particularly for non-small cell lung cancer (NSCLC), has recently been published. For patients with NSCLC, two randomized phase II trials also suggested that the addition of a radical local treatment results in encouraging survival data, with a good safety profile. A single-arm phase II finally showed a benefit when combining a radical local treatment with an anti-PD1 immunotherapy. This review describes the definitions of oligometastatic disease, the main prospective findings including radiation therapy, and prospects for oligometastatic NSCLC patients.
Collapse
Affiliation(s)
- A Levy
- Gustave-Roussy, département d'oncologie radiothérapie, 94805 Villejuif, France; Centre international des cancers thoraciques (CICT), Gustave-Roussy, 94805 Villejuif, France; Université Paris-Saclay, Inserm U1030, radiothérapie moléculaire, 94805 Villejuif, France; Université Paris-Saclay, faculté de médecine, 94270 Le Kremlin-Bicêtre, France.
| | - C Roux
- Centre international des cancers thoraciques (CICT), Gustave-Roussy, 94805 Villejuif, France; Département de radiologie, Gustave-Roussy, 94805 Villejuif, France
| | - O Mercier
- Centre international des cancers thoraciques (CICT), Gustave-Roussy, 94805 Villejuif, France; Université Paris-Saclay, faculté de médecine, 94270 Le Kremlin-Bicêtre, France; Département de chirurgie thoracique et vasculaire et transplantation cardiopulmonaire, groupe hospitalier Paris Saint-Joseph-Marie-Lannelongue, 92350 Le Plessis-Robinson, France
| | - J Issard
- Centre international des cancers thoraciques (CICT), Gustave-Roussy, 94805 Villejuif, France; Département de chirurgie thoracique et vasculaire et transplantation cardiopulmonaire, groupe hospitalier Paris Saint-Joseph-Marie-Lannelongue, 92350 Le Plessis-Robinson, France
| | - A Botticella
- Gustave-Roussy, département d'oncologie radiothérapie, 94805 Villejuif, France; Centre international des cancers thoraciques (CICT), Gustave-Roussy, 94805 Villejuif, France
| | - F Barlesi
- Centre international des cancers thoraciques (CICT), Gustave-Roussy, 94805 Villejuif, France; Gustave-Roussy Cancer Campus, Villejuif, France; Aix-Marseille université, Inserm, CNRS, CRCM, Marseille, France
| | - C Le Péchoux
- Gustave-Roussy, département d'oncologie radiothérapie, 94805 Villejuif, France; Centre international des cancers thoraciques (CICT), Gustave-Roussy, 94805 Villejuif, France
| |
Collapse
|